Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma-Reference-Cited by-同舟云学术

Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma

Published:2009-07 Issue:7 Volume:100 Page:1261-1266
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Lai Jiun-I.,Tzeng Cheng-Hwai,Chen Po-Min,Lin Jen-Kou,Lin Tzu-Chen,Chen Wei-Shone,Jiang Jeng-Kae,Wang Huann-Sheng,Wang Wei-Shu

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2009.01186.x/fullpdf

Reference36 articles.

1. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

2. Oxaliplatin: mechanism of action and antineoplastic activity;Raymond;Semin Oncol,1998

3. Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity;Saldivar;Gynecol Oncol,2007

4. Excision repair cross complementation group1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma;Luca;Clin Cancer Res,2007

5. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy;Zhou;Clin Cancer Res,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Excision repair cross‑complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence;Oncology Letters;2021-04-07

2. Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review;Frontiers in Pharmacology;2020-10-06

3. Association of XPD Lys751Gln gene polymorphism with susceptibility and clinical outcome of colorectal cancer in Pakistani population: a case–control pharmacogenetic study;Genes & Genomics;2020-10-06

4. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation;Drug Resistance Updates;2018-07

5. The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2017-12